GLP-1 (which stands for glucagon-like peptide-1) is a hormone that plays a crucial role in regulating blood sugar levels. It works by stimulating insulin production, slowing down digestion, and reducing appetite. Over the years, GLP-1 agonists have emerged as a promising treatment option for individuals with type 2 diabetes.
Recent studies have shown that GLP-1 agonists are effective in improving glycemic control in people with type 2 diabetes. They work by mimicking the effects of GLP-1, which increases insulin secretion from pancreatic beta-cells, suppresses glucagon secretion, and slows down gastric emptying.
The latest research suggests that GLP-1 agonists not only improve blood sugar control but also have additional benefits, such as promoting weight loss and reducing cardiovascular risk. In addition to their glucose-lowering effects, GLP-1 agonists have been shown to promote weight loss by reducing appetite and increasing feelings of fullness. They may also reduce the risk of cardiovascular disease in people with type 2 diabetes by improving blood pressure, lipid levels, and arterial function. Overall, GLP-1 agonists are a promising new option for managing type 2 diabetes and improving overall health outcomes.
Our clinic utilizes GLP-1’s when clinically appropriate.